Status:
COMPLETED
Optical Coherence Tomography (OCT) Data Collection Study
Lead Sponsor:
Optovue
Conditions:
No Eye Disease
Eligibility:
All Genders
18+ years
Brief Summary
Collect OCT data to evaluate the range and age trend of eye measurements.
Eligibility Criteria
Inclusion
- At least 18 years of age
- Able and willing to provide consent
- Able and willing to complete the required examininations and visit
- Refractive error within 8 diopters sphere and within 2 diopters cylinder in each eye
- Best corrected visual acuity of 20/30 or better in each eye
Exclusion
- History of leukemia, AIDS, dementia or multiple sclerosis
- Concomitant use of hydroxycloroquine or chloroquine
- Family history of glaucoma among first degree relatives
- Intraocular pressure of 22mm Hg or greater in either eye
- Unreliable or abnormal visual field
- Active ocular disease
- Previously diagnosed with glaucoma or glaucoma suspect
- Congenital ocular abnormalities
- Previous intra-ocular surgery or laser treatment (other than refractive surgery or uncomplicated cataract surgery greater than 6 months previously)
- Anatomic narrow angle
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01459731
Start Date
September 1 2011
End Date
March 1 2012
Last Update
May 2 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern California College of Optometry
Fullerton, California, United States, 92831
2
College of Optometry, Western University of Health Sciences
Pomona, California, United States, 91766
3
Buena Vista Eye Care
San Jose, California, United States, 95112
4
Illinois Eye Institute
Chicago, Illinois, United States, 60616